Franklin Templeton ETF Trust (HELX)
管理公司 · BATS · 系列 S000067393 · 在 SEC EDGAR 上查看 ↗
该基金的持仓数据尚未提供。
本页内容
基金流向（SEC报告）
- 上个月（三月 2026）
- +$0
- 截至三月 2026的季度
- +$1.9M
- 过去12个月
- +$7.8M
四月 2025 – 三月 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
完整构成 61 持仓
| 名称 | CUSIP | 价值 | % | 余额 | 类别 | 国家 |
|---|---|---|---|---|---|---|
| Guardant Health Inc | 40131M109 | $1.5M | 6.77 | 15718 | EC | US |
| NATERA INC | 632307104 | $1.4M | 6.65 | 7131 | EC | US |
| Krystal Biotech Inc | 501147102 | $1.1M | 5.32 | 4418 | EC | US |
| United Therapeutics Corporation | 91307C102 | $996K | 4.64 | 1680 | EC | US |
| Insmed Inc | 457669307 | $970K | 4.52 | 5932 | EC | US |
| Bridgebio Pharma Inc | 10806X102 | $905K | 4.22 | 12192 | EC | US |
| Ligand Pharmaceuticals Incorporated | 53220K504 | $757K | 3.53 | 3794 | EC | US |
| AstraZeneca PLC | — | $729K | 3.40 | 3695 | EC | GB |
| Adaptive Biotechnologies Corp | 00650F109 | $670K | 3.12 | 48245 | EC | US |
| Vertex Pharmaceuticals Incorporated | 92532F100 | $641K | 2.99 | 1435 | EC | US |
| Samsung Biologics Co Ltd | — | $640K | 2.99 | 652 | EC | KR |
| Medpace Holdings Inc. | 58506Q109 | $637K | 2.97 | 1327 | EC | US |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $578K | 2.69 | 748 | EC | US |
| Corteva Inc | 22052L104 | $578K | 2.69 | 6904 | EC | US |
| Alnylam Pharmaceuticals Inc. | 02043Q107 | $558K | 2.60 | 1687 | EC | US |
| Eli Lilly & Co. | 532457108 | $545K | 2.54 | 593 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $447K | 2.09 | 5957 | EC | US |
| Tempus AI Inc. | 88023B103 | $395K | 1.84 | 8726 | EC | US |
| BioNTech SE | 09075V102 | $386K | 1.80 | 4340 | EC | DE |
| Neurocrine Biosciences Inc | 64125C109 | $355K | 1.65 | 2693 | EC | US |
| Stoke Therapeutics Inc | 86150R107 | $343K | 1.60 | 10539 | EC | US |
| Twist Bioscience Corporation | 90184D100 | $341K | 1.59 | 7184 | EC | US |
| Argenx SE | — | $328K | 1.53 | 459 | EC | NL |
| PTC Therapeutics, Inc. | 69366J200 | $317K | 1.48 | 4652 | EC | US |
| Travere Therapeutics Inc | 89422G107 | $301K | 1.40 | 10129 | EC | US |
| Charles River Laboratories International, Inc. | 159864107 | $249K | 1.16 | 1445 | EC | US |
| CRISPR Therapeutics AG | — | $222K | 1.04 | 4671 | EC | CH |
| Repligen Corporation | 759916109 | $220K | 1.03 | 1866 | EC | US |
| Veracyte Inc | 92337F107 | $219K | 1.02 | 6788 | EC | US |
| Praxis Precision Medicines Inc | 74006W207 | $215K | 1.00 | 667 | EC | US |
| GRAIL Inc | 384747101 | $214K | 1.00 | 4138 | EC | US |
| Sartorius AG | — | $205K | 0.96 | 841 | EP | DE |
| Danaher Corporation | 235851102 | $199K | 0.93 | 1050 | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | $192K | 0.90 | 391 | EC | US |
| IQVIA Holdings Inc. | 46266C105 | $171K | 0.80 | 1005 | EC | US |
| BEAM THERAPEUTICS INC | 07373V105 | $168K | 0.78 | 7036 | EC | US |
| Jazz Pharmaceuticals PLC | — | $159K | 0.74 | 841 | EC | IE |
| Catalyst Pharmaceuticals Inc. | 14888U101 | $158K | 0.74 | 6375 | EC | US |
| Cadence Design Systems, Inc. | 127387108 | $151K | 0.71 | 545 | EC | US |
| Agilent Technologies Inc. | 00846U101 | $129K | 0.60 | 1136 | EC | US |
| Caredx Inc | 14167L103 | $129K | 0.60 | 7429 | EC | US |
| QIAGEN NV | — | $127K | 0.59 | 3175 | EC | NL |
| AnaptysBio Inc. | 032724106 | $113K | 0.53 | 2041 | EC | US |
| SAMSUNG EPIS HOLDINGS CO LTD | — | $113K | 0.53 | 350 | EC | KR |
| Tarsus Pharmaceuticals Inc | 87650L103 | $104K | 0.49 | 1487 | EC | US |
| Ultragenyx Pharmaceuticals Inc | 90400D108 | $100K | 0.47 | 4765 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $97K | 0.45 | 4107 | EC | US |
| Axsome Therapeutics Inc. | 05464T104 | $96K | 0.45 | 566 | EC | US |
| GeneDx Holdings Corp | 81663L200 | $90K | 0.42 | 1409 | EC | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | $85K | 0.39 | 974 | EC | US |
页 1
/ 2
← 上一页
下一页 →
机构持有人 (13F) 8 家申报者
在其季度SEC表格13F中报告持有该ETF的机构。仅限多头头寸；单个申报者可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
| 机构 | 价值 | % 已追踪的13F | 股份 | 类型 | 截至 |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1529544 | 40.48% | 38272 | 股份 | 2026年6月30日 |
| CITADEL ADVISORS LLC | $1350820 | 35.75% | 33800 | 股份 | 2026年6月30日 |
| LPL Financial LLC | $615622 | 16.29% | 15404 | 股份 | 2026年6月30日 |
| OSAIC HOLDINGS, INC. | $125643 | 3.33% | 3142 | 股份 | 2026年6月30日 |
| FRANKLIN RESOURCES INC | $106907 | 2.83% | 2675 | 股份 | 2026年6月30日 |
| HARBOUR INVESTMENTS, INC. | $50146 | 1.33% | 1255 | 股份 | 2026年6月30日 |
| HUNTINGTON NATIONAL BANK | $14 | 0.00% | 1 | 股份 | 2026年6月30日 |
| JPMORGAN CHASE & CO | $1 | 0.00% | 0 | 股份 | 2026年6月30日 |
同类基金
规模相似
| 基金 | 资产管理规模 |
|---|---|
| ELIL Direxion Shares ETF Trust | $21.5M |
| HDG ProShares Trust | $21.6M |
| PSCD Invesco Exchange-Traded Fund ... | $21.7M |
| UXOC First Trust Exchange-Traded F... | $21.8M |
| PQAP PGIM Rock ETF Trust | $21.9M |
| MEXX Direxion Shares ETF Trust | $21.4M |
| DTAN EA Series Trust | $21.4M |
| VEMY Virtus ETF Trust II | $21.3M |
| TMNS T. Rowe Price Exchange-Traded... | $21.2M |
| CFIT Cambria ETF Trust | $21.2M |